Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Optimal dose of esketamine + midazolam for pediatric preoperative sedation
ChiCTR2500102423Phase 4Recruiting
- Sponsor
- Linping District Women and Children Care Hospital
- Start
- May 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of esketamine in preoperative anxiety and None (5 arms), sponsored by Linping District Women and Children Care Hospital. Primary endpoint: Sedation success rate. Started May 2025; status: recruiting.
02
Drugs
esketamine
03
Conditions
preoperative anxiety
Beyond the preview
Go deeper on ChiCTR2500102423.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500102423.